SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Organovo Holdings, Inc. – ‘10-Q’ for 6/30/19 – ‘EX-32.1’

On:  Thursday, 8/8/19, at 4:07pm ET   ·   For:  6/30/19   ·   Accession #:  1564590-19-30763   ·   File #:  1-35996

Previous ‘10-Q’:  ‘10-Q’ on 2/7/19 for 12/31/18   ·   Next:  ‘10-Q’ on 11/7/19 for 9/30/19   ·   Latest:  ‘10-Q’ on 2/8/24 for 12/31/23

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 8/08/19  Organovo Holdings, Inc.           10-Q        6/30/19   54:5M                                     ActiveDisclosure/FA

Quarterly Report   —   Form 10-Q   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    537K 
 2: EX-31.1     Certification -- §302 - SOA'02                      HTML     23K 
 3: EX-31.2     Certification -- §302 - SOA'02                      HTML     23K 
 4: EX-32.1     Certification -- §906 - SOA'02                      HTML     22K 
11: R1          Document and Entity Information                     HTML     63K 
12: R2          Condensed Consolidated Balance Sheets               HTML     98K 
13: R3          Condensed Consolidated Balance Sheets               HTML     28K 
                (Parenthetical)                                                  
14: R4          Unaudited Condensed Consolidated Statements of      HTML     66K 
                Operations and Other Comprehensive Loss                          
15: R5          Unaudited Condensed Consolidated Statements of      HTML     45K 
                Stockholders' Equity                                             
16: R6          Unaudited Condensed Consolidated Statements of      HTML     95K 
                Cash Flows                                                       
17: R7          Description of Business                             HTML     23K 
18: R8          Summary of Significant Accounting Policies          HTML     59K 
19: R9          Stockholders' Equity                                HTML    224K 
20: R10         Collaborative Research, Development, and License    HTML     24K 
                Agreements                                                       
21: R11         Commitments and Contingencies                       HTML     24K 
22: R12         Leases                                              HTML    121K 
23: R13         Concentrations                                      HTML     22K 
24: R14         Related Parties                                     HTML     24K 
25: R15         Subsequent Events                                   HTML     24K 
26: R16         Summary of Significant Accounting Policies          HTML     76K 
                (Policies)                                                       
27: R17         Stockholders' Equity (Tables)                       HTML    218K 
28: R18         Leases (Tables)                                     HTML    116K 
29: R19         Summary of Significant Accounting Policies -        HTML     74K 
                Additional Information (Detail)                                  
30: R20         Stockholders' Equity - Schedule of Stock-based      HTML     27K 
                Compensation Expense (Detail)                                    
31: R21         Stockholders' Equity - Stock-based Compensation     HTML     36K 
                Expense and Valuation Information - Additional                   
                Information (Detail)                                             
32: R22         Stockholders' Equity - Fair Value of Employee       HTML     32K 
                Stock Options (Detail)                                           
33: R23         Stockholders' Equity - Fair Value of Employee       HTML     20K 
                Stock Options (Parenthetical) (Detail)                           
34: R24         Stockholders' Equity - Fair Value of Employee       HTML     37K 
                Stock Purchase Plan (Detail)                                     
35: R25         Stockholders' Equity - Preferred Stock -            HTML     22K 
                Additional Information (Detail)                                  
36: R26         Stockholders' Equity - Common Stock - Additional    HTML     64K 
                Information (Detail)                                             
37: R27         Stockholders' Equity - Restricted Stock Awards,     HTML     87K 
                Restricted Stock Units and Performance-Based                     
                Restricted Stock Units - Additional Information                  
                (Detail)                                                         
38: R28         Stockholders' Equity - Summary of Company's         HTML     48K 
                Restricted Stock Unit Activity and                               
                Performance-Based Restricted Stock Unit Activity                 
                (Detail)                                                         
39: R29         Stockholders' Equity - Summary of Stock Option      HTML     53K 
                Activity (Detail)                                                
40: R30         Stockholders' Equity - Stock Options and Employee   HTML     53K 
                Stock Purchase Plan - Additional Information                     
                (Detail)                                                         
41: R31         Stockholders' Equity - Summary of Warrant Activity  HTML     44K 
                (Detail)                                                         
42: R32         Stockholders' Equity - Warrants - Additional        HTML     28K 
                Information (Detail)                                             
43: R33         Stockholders' Equity - Common Stock Reserved for    HTML     38K 
                Future Issuance (Detail)                                         
44: R34         Collaborative Research, Development, and License    HTML     43K 
                Agreements - Additional Information (Detail)                     
45: R35         Leases - Additional Information (Details)           HTML     55K 
46: R36         Leases - Schedule of Impact of Adoption of ASC 842  HTML     43K 
                on Consolidated Balance Sheet (Details)                          
47: R37         Leases - Summary of Lease Liabilities and           HTML     37K 
                Corresponding Right-of-use assets (Details)                      
48: R38         Leases - Summary of Cash Flows Associated with      HTML     20K 
                Company's Leases (Details)                                       
49: R39         Leases - Future Lease Payments Relating to          HTML     43K 
                Operating Lease Liabilities (Detail)                             
50: R40         Related Parties - Additional Information (Detail)   HTML     35K 
51: R41         Subsequent Events - Additional Information          HTML     39K 
                (Detail)                                                         
53: XML         IDEA XML File -- Filing Summary                      XML     95K 
52: EXCEL       IDEA Workbook of Financial Reports                  XLSX     61K 
 5: EX-101.INS  XBRL Instance -- onvo-20190630                       XML   1.22M 
 7: EX-101.CAL  XBRL Calculations -- onvo-20190630_cal               XML    104K 
 8: EX-101.DEF  XBRL Definitions -- onvo-20190630_def                XML    439K 
 9: EX-101.LAB  XBRL Labels -- onvo-20190630_lab                     XML    894K 
10: EX-101.PRE  XBRL Presentations -- onvo-20190630_pre              XML    709K 
 6: EX-101.SCH  XBRL Schema -- onvo-20190630                         XSD    123K 
54: ZIP         XBRL Zipped Folder -- 0001564590-19-030763-xbrl      Zip    111K 


‘EX-32.1’   —   Certification — §906 – SOA’02


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 <!   C: 

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q of Organovo Holdings, Inc. (the “Company”) for the period ended June 30, 2019, as filed with the Securities and Exchange Commission (the “Report”), I, Taylor Crouch, Chief Executive Officer and President and I, Craig Kussman, Chief Financial Officer of the Company hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

The information in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: August 8, 2019

 

/s/ Taylor Crouch 

Taylor Crouch

Chief Executive Officer and President

(Principal Executive Officer)

 

/s/ Craig Kussman 

Craig Kussman

Chief Financial Officer

(Principal Financial Officer)

 

A signed original of this written statement required by Section 906 has been provided to Organovo Holdings, Inc. and will be retained by Organovo Holdings, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

This certification accompanies the Form 10-Q to which it relates, is not deemed filed with the Securities and Exchange Commission, and is not to be incorporated by reference into any filing of Organovo Holdings, Inc. under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of the Form 10-Q), irrespective of any general incorporation language contained in such filing.


Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-Q’ Filing    Date    Other Filings
Filed on:8/8/19None on these Dates
For Period end:6/30/19
 List all Filings 
Top
Filing Submission 0001564590-19-030763   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., May 17, 1:11:31.1pm ET